share_log

HC Wainwright & Co. Reiterates Buy on Galectin Therapeutics, Maintains $11 Price Target

HC Wainwright & Co. Reiterates Buy on Galectin Therapeutics, Maintains $11 Price Target

HC Wainwright & Co.重申买入Galectin Therapeutics,维持11美元的目标股价
Benzinga ·  04/09 11:57

HC Wainwright & Co. analyst Ed Arce reiterates Galectin Therapeutics (NASDAQ:GALT) with a Buy and maintains $11 price target.

HC Wainwright & Co. 分析师埃德·阿尔塞重申Galectin Therapeutics(纳斯达克股票代码:GALT)的买入并维持11美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发